Yes, you are right. but also because big pharmas

are desparately looking for new pipeline products. four biotech companies my hu*****and put on his list as acqustion candidates early this year all got acquired with unbelieverably high premium. you know this sector well and you can make some good bets here.
but they are expensive now...
pay attention to small caps with deep value. they probably will outperform if the bailout plan goes through.

请您先登陆,再发跟帖!